rs2480256 — CYP2E1

3' UTR variant that increases CYP2E1 expression, raising hepatotoxicity risk from acetaminophen, isoniazid, ethanol, and occupational solvents

See your personal result for CYP2E1

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

CYP2E1 — When the Detox Engine Runs Hot

CYP2E1 (cytochrome P450 2E1) is the liver's chemical-processing workhorse for a surprisingly wide range of exposures: acetaminophen (paracetamol), isoniazid (tuberculosis antibiotic), ethanol at moderate-to-high doses, volatile anesthetics (sevoflurane, isoflurane), and industrial chemicals such as benzene, chloroform, and styrene. The rs2480256 variant in CYP2E1's [3' untranslated region | The 3' UTR is the section of mRNA after the stop codon; it contains binding sites for regulatory microRNAs that control mRNA stability and translation efficiency] acts as a regulatory dial: the A allele increases how much of this enzyme the liver produces. More enzyme means faster processing — but for substrates like acetaminophen, that creates more toxic intermediates, not safer metabolism.

The Mechanism

rs2480256 sits in the 3' UTR of CYP2E1, a region that serves as a docking site for [microRNAs | Small non-coding RNA molecules that bind to the 3' UTR and suppress translation or trigger mRNA degradation] that tune down gene expression. A single nucleotide change at this position can alter or abolish a microRNA binding site, freeing the mRNA from its brakes and allowing the cell to produce more enzyme. Liao et al. (2011)11 Liao et al. (2011)
Liao LH, Zhang H, Lai MP, et al. Single-nucleotide polymorphisms and haplotype of CYP2E1 gene associated with systemic lupus erythematosus in Chinese population. Arthritis Research & Therapy, 2011;13(1):R9. confirmed this transcriptional dose-response in peripheral blood mononuclear cells: cells from A/A homozygotes showed the highest CYP2E1 mRNA levels, followed by A/G heterozygotes, with G/G carriers expressing the least.

For acetaminophen, elevated CYP2E1 activity means more [NAPQI | N-acetyl-p-benzoquinone imine: the reactive, hepatotoxic metabolite generated when CYP2E1 oxidizes acetaminophen; normally neutralized by glutathione, but excess NAPQI depletes GSH and directly damages liver cells] is produced per dose. This toxic intermediate is normally neutralized by glutathione; when NAPQI production outpaces glutathione supply, liver cell injury follows. Chronic ethanol consumption further upregulates CYP2E1 protein and creates a dangerous synergy with acetaminophen — a combination that features prominently in acetaminophen-related acute liver failure cases.

The Evidence

The primary clinical evidence for rs2480256 is an association study in [systemic lupus erythematosus (SLE) | An autoimmune condition driven by immune dysregulation and inflammation; oxidative stress from elevated CYP2E1 may promote the immune activation that underlies SLE] by Liao et al.22 Liao et al.
Liao LH et al. Single-nucleotide polymorphisms and haplotype of CYP2E1 gene associated with systemic lupus erythematosus. Arthritis Res Ther, 2011;13:R9.. In a two-stage case-control design enrolling 876 SLE patients and 680 controls from a Chinese Han population, the A allele was associated with increased SLE risk (OR = 1.165, 95% CI 1.073–1.265, p = 2.75×10⁻⁴). A/A homozygotes showed substantially higher susceptibility (OR = 1.464, 95% CI 1.259–1.702, p = 7.48×10⁻⁷). A combined haplotype analysis with the nearby rs8192772 strengthened the signal. The mechanistic link: CYP2E1 generates [reactive oxygen species | Chemically reactive molecules containing oxygen (superoxide, hydrogen peroxide, hydroxyl radical) that damage DNA, proteins, and lipid membranes; chronic overproduction drives inflammatory and autoimmune processes] as a byproduct of its oxidative reactions; individuals with constitutively higher expression carry greater baseline oxidative burden.

For antitubercular drug toxicity, a 2025 review33 2025 review
Bishnu D et al. Unraveling the Role of CYP2E1 in Antitubercular Drug-Induced Hepatotoxicity. Int J Hepatol, 2025. confirmed that CYP2E1 polymorphisms are a significant determinant of individual susceptibility to isoniazid-induced hepatotoxicity, with higher-expressing genotypes converting more isoniazid to hepatotoxic hydrazine intermediates.

Practical Actions

For A/A and A/G individuals, the key concern is acetaminophen safety at high or repeated doses, particularly in the context of alcohol use or fasting. Fasting and ketosis independently upregulate CYP2E1 protein regardless of genotype; an already-elevated baseline combined with acute fasting creates heightened NAPQI generation from even standard acetaminophen doses.

Occupational chemical exposures represent another domain where genotype matters: benzene, chloroform, trichloroethylene, and other industrial solvents are bioactivated by CYP2E1 into more reactive (and more genotoxic) derivatives. Workers in solvent-exposure settings who carry the A allele process more activated metabolite per unit exposure.

Interactions

rs2480256 acts in the same pathway as rs2515641, a synonymous variant in CYP2E1 exon 8 that has the opposite effect: the T allele reduces expression. A carrier of the rs2480256 A allele (higher expression) who also carries the rs2515641 C allele (wild-type expression, no reduction) will have the combined high-expression phenotype. The two variants tag different aspects of CYP2E1 regulation — 3' UTR microRNA-mediated in the case of rs2480256, codon-usage–mediated in the case of rs2515641 — and are not in complete linkage disequilibrium, meaning they can be assessed independently.

Concurrent use of CYP2E1 substrates amplifies risk in A/A carriers: combining acetaminophen with isoniazid, or taking either during heavy alcohol use, creates competitive substrate overload and dramatically increases hepatotoxic intermediate formation. In high-expression A/A individuals, even therapeutic acetaminophen doses combined with alcohol can stress hepatic glutathione reserves.

Drug Interactions

acetaminophen increased_toxicity literature
isoniazid increased_toxicity literature
ethanol altered_metabolism literature
sevoflurane dose_adjustment literature
isoflurane dose_adjustment literature
benzene increased_toxicity literature

Genotype Interpretations

What each possible genotype means for this variant.

GG Normal Metabolizer Normal

Standard CYP2E1 expression — typical processing of acetaminophen and solvents

You carry two copies of the G allele at rs2480256. The G allele is associated with baseline CYP2E1 expression — the standard level that most people carry. Approximately 60% of the global population share this genotype (rising to roughly 77% in East Asians and Africans with lower A frequencies; in African populations where A is common, GG frequency is around 11%). Your processing of acetaminophen, isoniazid, ethanol, and occupational solvents through CYP2E1 occurs at expected rates.

AG Intermediate Metabolizer Intermediate

One A allele — modestly elevated CYP2E1 expression, heightened acetaminophen caution

The AG genotype represents intermediate CYP2E1 expression. The Liao et al. study (PMID 21281483) showed A/G individuals had intermediate mRNA levels, consistent with a codominant expression model where each A allele adds incrementally to enzyme output. For acetaminophen, this means slightly more NAPQI per dose; at therapeutic doses (325–1,000 mg), hepatic glutathione is normally sufficient to neutralize this. Risk accrues with stacking: regular use at high doses (3,000+ mg/day), combination with alcohol, or use during prolonged fasting.

For isoniazid (TB antibiotic), increased CYP2E1 expression paradoxically raises, not lowers, toxicity risk. CYP2E1 converts isoniazid to hepatotoxic hydrazine; higher enzyme activity produces more toxic intermediate per dose.

AA High-Expression Metabolizer High

Two A alleles — highest CYP2E1 expression, increased hepatotoxicity risk from acetaminophen and isoniazid

The AA genotype confers the highest CYP2E1 expression of the three rs2480256 genotypes. The Liao et al. 2011 study (n=1,556) found AA individuals had significantly higher CYP2E1 mRNA in peripheral blood mononuclear cells, and the AA genotype carried substantially elevated SLE risk (OR 1.464, p=7.48×10⁻⁷). The mechanistic pathway: elevated CYP2E1 generates reactive oxygen species as a byproduct of all its oxidation reactions, and chronic oxidative stress drives the immune dysregulation that underlies autoimmune conditions including SLE.

For acetaminophen, the practical consequence is a meaningfully narrower safe dose window. At 4,000 mg/day (the label maximum), AA individuals generate substantially more NAPQI than GG individuals. Combined with chronic alcohol use — which further induces CYP2E1 protein by 4- to 10-fold — the risk of subclinical liver injury at "safe" labelled doses becomes clinically meaningful. Fasting and low-carbohydrate diets also upregulate CYP2E1, creating a vulnerable state independent of genotype.

For isoniazid, higher CYP2E1 activity amplifies conversion to acetylhydrazine and hydrazine, the intermediates responsible for isoniazid-induced hepatotoxicity. This is additive with slow NAT2 acetylator status, which independently slows isoniazid clearance.

For occupational solvents, benzene is bioactivated by CYP2E1 to benzene oxide and other reactive metabolites that cause DNA strand breaks and are linked to leukemia and bladder cancer at sustained exposure levels. AA carriers who work in petroleum refining, shoe manufacturing, rubber, printing, or chemical industries face a higher effective carcinogen dose per unit of benzene exposure.